Given their careful choice of wording, its likely that intermediary processing between getting the blood sample and running the test is needed. In fact, simply

Given their careful choice of wording, its likely that intermediary processing between getting the blood sample and running the test is needed. In fact, simply be requiring the pipetting, they are already saying that they do no intend doctors or nurses to use this device - this is purely meant to be used in a laboratory context (note: there are lots of hospital labs). This device as it is is clearly meant 'For Research Use' only. The benefit of this device for their use will be relatively narrow. In a patient setting, the benefits of fast, on demand testing is obvious (for certain tests). In a research environment, where they will likely already have bulk PCR processes ready, the benefit is less clear. I work at a company that works in this field - we target DNA instead, and only look at one gene. We have FDA approval for high complexity lab use (https://wwwn.cdc.gov/clia/Resources/TestComplexities.aspx https://wwwn.cdc.gov/clia/Resources/TestComplexities.aspx). From my experience, getting this down to the doctor/nurse level is ridiculously hard, and getting approval for 96 different tests will require a ridiculous amount of capital. My guess is that this is a first gen product designed to work as proof of concept and generate some cash flow so they can bootstrap and move down the complexity chain towards the patient. One thing to note is that 'specialized personnel' are actually pretty cheap given the recent surge in underemployed biochem graduates.